Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402854 · ClinicalTrials.gov registry record · NA
tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
A NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Burke Medical Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03402854: Recruiting NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Burke Medical Research Institute.
NCT03402854 is a NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy that is actively recruiting participants, run by Burke Medical Research Institute. The registered enrollment target is 80 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03402854, a NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, is actively recruiting participants, sponsored by Burke Medical Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test the efficacy of transcranial direct current stimulation combined with bimanual training on hand function in children with unilateral spastic cerebral palsy (USCP). Children who enroll in the protocol will be randomized to receive either sham (not stimulating) tDCS plus bimanual training, or active (stimulating) tDCS plus bimanual training.
Conditions Studied
Interventions
- DEVICE active transcranial direct current stimulation
- BEHAVIORAL bimanual training
Study Locations (1)
New York
- Burke Medical Research Institute - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT03402854 shows while recruiting
NCT03402854 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (65% lower).
The record links to 5 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 2 interventions - of which active transcranial direct current stimulation is the first listed.
NCT03402854 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03402854 about?
NCT03402854 is a clinical study titled "tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy". The goal of this study is to test the efficacy of transcranial direct current stimulation combined with bimanual training on hand function in children with unilateral spastic cerebral palsy (USCP). Children who enroll in the protocol will be randomized to receive either sham (not stimulating) tDCS p...
What is the current status of trial NCT03402854?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2019-12-01. Estimated completion is 2025-08-31.
What conditions does trial NCT03402854 study?
This clinical trial studies the following conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy, Spastic Hemiplegia, Spastic Hemiparesis, Spastic Hemiplegic Cerebral Palsy.
What interventions are being tested in trial NCT03402854?
The interventions under investigation include: active transcranial direct current stimulation (DEVICE), bimanual training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03402854?
This trial is sponsored by Burke Medical Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03402854 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03402854's enrollment target sits among peer trials
80 28th of 91 higher than 62 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI